Have gotten full advance for 110 mn doses, clarifies: Serum CEO Poonawalla

Have gotten full advance for 110 mn doses, clarifies: Serum CEO Poonawalla



Pune-based vaccine maker Serum Institute of India will provide 220 million doses to the Centre, state governments and personal hospitals within the subsequent few months, in keeping with the most recent numbers given out by the corporate.


In a press release, Adar Poonawalla, CEO of SII, stated on Monday that the agency had obtained whole orders of 260 million doses from the federal government. Out of that, greater than 150 million doses have been provided. “We now have additionally bought one hundred pc advance of Rs 1,732.5 crore for the following tranche of 110 million doses within the subsequent few months,” he stated.



As well as, one other 110 million doses can be provided to state governments and personal hospitals within the subsequent few months, making it a complete of 220 million. In an interview to a information channel on April 21, Poonawalla had stated, “This contemporary 110 million doses contract was agreed upon a couple of month in the past and so we’re beginning to provide that from this month.”


He was talking within the context of the longer term value to the Centre and state governments.


Poonawalla, who left for the UK just lately, stated in an interview that he was getting threatening calls from highly effective folks in India for delivering vaccine.

Pricey Reader,

Enterprise Commonplace has at all times strived arduous to supply up-to-date data and commentary on developments which might be of curiosity to you and have wider political and financial implications for the nation and the world. Your encouragement and fixed suggestions on the way to enhance our providing have solely made our resolve and dedication to those beliefs stronger. Even throughout these tough instances arising out of Covid-19, we proceed to stay dedicated to maintaining you knowledgeable and up to date with credible information, authoritative views and incisive commentary on topical problems with relevance.

We, nevertheless, have a request.

As we battle the financial impression of the pandemic, we’d like your assist much more, in order that we will proceed to give you extra high quality content material. Our subscription mannequin has seen an encouraging response from lots of you, who’ve subscribed to our on-line content material. Extra subscription to our on-line content material can solely assist us obtain the targets of providing you even higher and extra related content material. We imagine in free, honest and credible journalism. Your assist via extra subscriptions may also help us practise the journalism to which we’re dedicated.

Assist high quality journalism and subscribe to Enterprise Commonplace.

Digital Editor


https://www.business-standard.com/article/corporations/have-got-full-advance-for-110-mn-doses-serum-ceo-adar-poonawalla-121050400039_1.html